Impact of an HIV Care Coordination Program on the Timeliness of Viral Suppression and Immune Recovery Among Clients Newly Diagnosed with HIV

  • McKaylee M. RobertsonEmail author
  • Kate Penrose
  • Denis Nash
  • Graham Harriman
  • Sarah L. Braunstein
  • Bruce Levin
  • Mary K. Irvine
Original Paper


We compared the time to immune recovery and viral suppression (VS) among people newly diagnosed with HIV who enrolled in the HIV Care Coordination Program (CCP), a comprehensive medical case management program, with a propensity matched group of newly diagnosed people who did not enroll. CCP enrollees had more rapid VS (≤ 200 copies/mL) [hazards ratio (HR) 1.17; 95% confidence interval 1.02–1.34] but no more rapid immune recovery (≥ two successive CD4 counts > 500 cells/mm3) (HR 0.98; 0.84–1.13). Relative to usual care, the CCP may expedite VS (though not immune recovery) for newly diagnosed HIV patients and therefore lower forward transmission risk.


HIV Viral suppression Medical case management Immunologic recovery New HIV diagnoses Care coordination Comparative effectiveness 


Hemos comparado el tiempo de recuperación del sistema inmunológico y la supresión viral (VS) entre personas recién diagnosticadas con VIH inscritas en el Programa de Coordinación de Atención del VIH (PCC), un programa integral que maneja casos médicos, con un grupo de personas diagnosticadas recientemente que no se inscribieron en el programa. Los inscritos en PCC tuvieron una supresión viral VS más rápida (≤ 200 copias/ml) (razón de riesgos [HR] 1.17; intervalo de confianza del 95% 1.02-1.34) pero no presentaron una recuperación inmune más rápida (≥ dos recuentos sucesivos de CD4 > 500 células/mm3) (HR: 0,98; 0,84-1,13). En relación con la atención habitual, el CCP puede acelerar la supresión viral VS (pero no la recuperación inmune) para los pacientes con VIH recién diagnosticados y, por lo tanto, reduce el riesgo de transmisión en lo sucesivo.



The authors are indebted to: Kate Taylor for assistance with manuscript preparation, the Ryan White Part A Care Coordination Program staff for their dedication to the delivery of comprehensive services, their continual participation in reporting on this intervention, and their shared commitment to rigorous evaluation and the integration of findings into practice; and the members of the study Community Advisory Board, for their guidance and critical input at various stages of this work. This work was completed as part of the Costs, Health Outcomes and Real-world Determinants of Success in HIV Care Coordination (CHORDS) Study.


This work was supported by the National Institute of Mental Health of the National Institutes of Health (Grant No. R01 MH101028).


  1. 1.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefGoogle Scholar
  2. 2.
    Insight Start Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRefGoogle Scholar
  3. 3.
    Battegay M, Nuesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis. 2006;6(5):280–7.CrossRefGoogle Scholar
  4. 4.
    Colasanti J, Sumitani J, Mehta CC, Zhang Y, Nguyen ML, Del Rio C, et al. Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the Southern United States. Open Forum Infect Dis. 2018;5(6):ofy104.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Irvine MK, Chamberlin SA, Robbins RS, Myers JE, Braunstein SL, Mitts BJ, et al. Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clin Infect Dis. 2015;60(2):298–310.CrossRefGoogle Scholar
  6. 6.
    Nash D, Robertson MM, Penrose K, Chamberlin S, Robbins RS, Braunstein SL, et al. Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes. PLoS ONE. 2018;13(9):e0204017.CrossRefGoogle Scholar
  7. 7.
    Robertson MM, Waldron L, Robbins RS, Chamberlin S, Penrose K, Levin B, et al. Using registry data to construct a comparison group for programmatic effectiveness evaluation: the New York City HIV Care Coordination Program. Am J Epidemiol. 2018;187(9):1980–9.CrossRefGoogle Scholar
  8. 8.
    Robertson MM, Penrose K, Irvine MK, Robbins RS, Kulkarni S, Braunstein SL, et al. Impact of an HIV Care Coordination Program on durable viral suppression. J Acquir Immune Defic Syndr. 2019;80(1):46–55.CrossRefGoogle Scholar
  9. 9.
    Collaboration of Observational HIVEREiE, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4 ≥ 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433–45.CrossRefGoogle Scholar
  10. 10.
    Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.CrossRefGoogle Scholar
  11. 11.
    Gardner LI, Giordano TP, Marks G, Wilson TE, Craw JA, Drainoni ML, et al. Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics. Clin Infect Dis. 2014;59(5):725–34.CrossRefGoogle Scholar
  12. 12.
    Robertson MM, Braunstein SL, Hoover DR, Li S, Nash D. Timeliness of human immunodeficiency virus diagnosis and antiretroviral treatment initiation in the era of universal testing and treatment. J Infect Dis. 2019;220(4):648–56.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute for Implementation Science in Population Health (ISPH)City University of New York (CUNY)New York CityUSA
  2. 2.Graduate School of Public Health and Health PolicyCity University of New York (CUNY)New York CityUSA
  3. 3.Bureau of HIV/AIDS Prevention and ControlNew York City Department of Health and Mental HygieneNew York CityUSA
  4. 4.Department of Biostatistics, Mailman School of Public HealthColumbia UniversityNew YorkUSA

Personalised recommendations